martedì 23 ottobre 2007

Non somministrare farmaci da banco per raffreddore o tosse a bambini al sotto dei 6 anni

La notizia che propongo viene dagli Stati Uniti ma può essere di lezione anche in Italia e riguarda la raccomandazione da parte della FDA di non somministrare farmaci da banco contro la tosse o il raffreddore a bambini al di sotto dei sei anni. Il motivo è da un lato il dubbio sull'efficacia, dall'altro il rischio di tossicità.
Quindi usare i farmaci (qualunque) solo se necessari e di provata efficacia.

FDA Advisors Propose Broader Withdrawal of Childhood Cold Medicines

Over-the-counter cold medicines, even those formulated for children, should not be given to those under the age of 6 years, an FDA advisory panel recommends.

The panel voted 13 to 9 to ban the marketing of pediatric products, including such popular brands as Robitussin and Triaminic, for children age 5 or younger, according to a New York Times story. The agency does not always follow its advisory panels' recommendations; if it does, it must follow a process that can take at least a year, according to the Times report.

The vote came after a citizens' petition from Maryland health officials and others in March. The petition says that in the light of "growing evidence for lack of efficacy and risk of toxicity," it is "simply not credible for FDA's position to remain that these products are 'generally recognized as safe and effective' for children under six."

Nessun commento: